Does the NCI Best Case Series Program evaluate CAM therapies for their effectiveness as a cancer treatment?
No. An evaluation of a treatment’s effectiveness is generally done by analyzing the results of well-designed and well-conducted clinical trials. Rather, the goal of the NCI Best Case Series Program is to provide an assessment of the quality of available data and its utility as support for the justification of NCI-initiated research.